← Back to Nuqta Atlas
Editorially curated · om-tb-genomic-surveillance
Oman Tuberculosis Genomic Surveillance Studies
Uses whole-genome sequencing and geospatial epidemiology to study TB lineage diversity, transmission clusters and resistance in Oman.
01 / Project overview
What the record establishes.
- Geographic scope
- National TB cases and archived isolates
- Project type
- Pathogen genomic-surveillance programme
- Research domain
- Tuberculosis transmission and drug resistance
- Years
- 2021–
- Lifecycle status
- active
- Status basis
- A 2023 national WGS study has a public BioProject, and a later expanded analysis covers isolates from 2008-2022; together they show an ongoing surveillance research line.
- Status evidence date
- 2026-08-15
- Scale
- Initial national insight: 70 genomes from 2021; expanded study: 735 isolates from 2008-2022 with 96 sequenced.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Oman Ministry of Health Central Public Health Laboratories
- Partner organizations
- Not stated
- Organism / population
- Mycobacterium tuberculosis isolates from Oman
03 / Data and access
What exists and how it can be reached.
Data types
- bacterial whole-genome sequencing
- geospatial epidemiology
- drug-resistance profiling
Data access
Public BioProject metadata and sequence data
Identifiers
- BioProject
PRJNA994284 - PubMed
PMID:37075829 - PMCID
PMCID:PMC12819509
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National surveillance studies with a public accession and primary publications.
Editorial note
Grouped as one surveillance line to avoid treating sequential publications as unrelated projects.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0